Vial Provider Comparison
Core Peptides vs Direct Peptides
Same category. Different operational transparency.
Core Peptides
Grey Market VendorUSE CAUTION
61/ 100
Vial Trust Score
Direct Peptides
Grey Market VendorUSE CAUTION
65/ 100
Vial Trust Score
SignalCore PeptidesDirect Peptides
Pharmacy Disclosure
Do they name their pharmacy partner?
✕No pharmacy partner named
✕No pharmacy partner named
Physician Oversight
Are prescribing clinicians named?
✕No clinician disclosure
✕No clinician disclosure
Pricing Transparency
Is pricing shown before signup?
✓Public pricing (Mid)
✓Public pricing (Premium)
Federal Enforcement History
Any FDA, DEA, or OIG actions?
✓No federal actions found
✓No federal actions found
State Availability
How widely is care available?
✕Coverage not disclosed
✓Available in all 50 states
Membership Model
Is a paid membership required?
✓No membership required
✓No membership required
Data & Privacy
Any reported HIPAA breaches?
✓No breaches on record
✓No breaches on record
Less disclosure
Core Peptides
Gaps in pharmacy disclosure, physician oversight, and state availability.
More disclosure
Direct Peptides
Discloses more across state availability.
Updated May 26, 2026
Scores based on operational, compliance, and transparency signals tracked by Vial.
Found this helpful? Share it.
Help others get informed.
Other matchups
Related comparisons
61Core Peptides
65SwissChems
4-point gapSee the gap →
65Direct Peptides
65SwissChems
Same scoreSee the gap →
61Core Peptides
64Hallandale Health
3-point gapSee the gap →
65Direct Peptides
64Hallandale Health
1-point gapSee the gap →
64Blue Sky Peptide
61Core Peptides
3-point gapSee the gap →
64Blue Sky Peptide
65Direct Peptides
1-point gapSee the gap →